Clovis Oncology, Inc. (CLVS) has seen some recent activity in the market and its stock closed at $6.01 yesterday. Traders are starting to take notice of CLVS as the stock traded as high as $6.40 and as low as $5.90 in the prior market trading day.

Clovis Oncology, Inc. (CLVS) average trading volume is 4.78M. However, in the prior market trading day Clovis Oncology, Inc. (CLVS) traded 5,644,246 shares. The 1st downside support level on CLVS is $5.96 and the 1st resistance level on CLVS is $10.15. CLVS 50day moving average is $5.93 and CLVS 200day moving average is $6.70.

Clovis Oncology, Inc. (CLVS) current performance has been indicated by the recent movement in CLVS stock. CLVS has performed -15.71% over the past 4 weeks, CLVS has performed -5.65% over the past 3 months and CLVS has shown 87.52% over the past 365 days. Clovis Oncology, Inc. (CLVS) has a 12 month range of $2.93 to $17.37. Clovis Oncology, Inc. (CLVS) is trading 105.12% from its 12 month low and -65.40% from its 12 month high. Clovis Oncology, Inc. (CLVS) is indicating a 44.57% short float indicating the quantity short in the float.

CLVS has 88.20M shares outstanding and 85.08M shares in the float. Clovis Oncology, Inc. (CLVS) at this time has a market cap of $545.47M and income of -385.20M. The EPS next quarter for CLVS is -0.99 and anticipated EPS next year is 40.20%. The market cap of Clovis Oncology, Inc. (CLVS) at $545.47M represents how many Traders own shares of CLVS and is calculated off the last price ($6.01) of CLVS and the quantity of shares outstanding (88.20M) with Clovis Oncology, Inc. (CLVS).

Clovis Oncology, Inc. (CLVS) has total cash (mrq) of 261.44M, total cash per share (mrq) of 2.96, total debt of CLVS remains at 615.95M. Clovis Oncology, Inc. (CLVS) running cash flow (ttm) is -269.48M, CLVS leveraged free cash flow (ttm) is -149.04M.

CLVS is trading -2.98% below (bearish) its SMA20, 4.14% above (bullish) its SMA50 and -15.95% below (bearish) its SMA200.